BUB1B and hepatocellular carcinoma: Our study confirmed that BUB1B is overexpressed in HCC tissues and cell lines, and the overexpression of BUB1B is highly correlated to adverse clinicopathological features, lower recurrence‐free survival and overall survival rate in patients with HCC.